CYTO Research and Charts

CYTO - Altamira Therapeutics Ltd (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-19 (Delayed quote data 2024-12-19)

Last 0.30	Change ⇓ -0.11 (0.00%)	Volume 830,271
	Open 0.42	High 0.43	Low 0.30

8EMA (Daily) 0.41	40EMA (Daily) 0.48	50EMA (Daily) 0.51	STO (Daily) 7.778	MACD Hist (Daily) -0.019
8EMA (Weekly) 0.442	40EMA (Weekly) 0.95	50EMA (Weekly) 1.18	STO (Weekly) 3.935	MACD Hist (Weekly) 0.002


Company Profile
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.